Stellar gets European nod for NeoVisc single dose

Stellar Pharmaceuticals (OTCQB, OTCBB:SLXCF) has received CE Mark for its NeoVisc single dose viscosupplement therapy, denoting conformity with European standards for safety and allowing the company to market both its NeoVisc triple dose and its single dose products in the European Union. “This approval is a significant milestone in Stellar’s global licensing strategy, as osteoarthritis [...]

Stellar taps familiar face as advisory consultant for U.S. market

Stellar Pharmaceuticals (OTCQB:SLXCF) has engaged the services of Advisory Associates (AAI) as an advisory consultant to locate leads and assist in negotiating a license deal for the company’s products, NeoVisc and Uracyst for the U.S. market. “I am pleased that we were able to enter into this agreement with AAI given its experience and proven [...]

Stellar outlines strategy at Cowen conference; gets Chinese patent

Upcoming milestones for Stellar Pharmaceuticals (OTCBB:SLXCF) provide for near-and mid-term investment triggers, President and CEO, Peter Riehl, said in a presentation at the SG Cowen healthcare conference in Boston. Stellar, which is only one of three Canadian companies presenting at the Cowen conference, is aggressively expanding its global out-licensing programs for its two lead products [...]

Stellar plugging bladder wall around the world

In 2003, Lana Tenney began chemotherapy following her breast cancer surgery.  And as stressful as that was, things quickly worsened.  She developed a side-effect from chemotherapy called cystitis, a painful bladder condition that oncologists see in 10%-to-15% of cancer patients, who feel an urge to urinate 20-to-30 times a day, whether they can or can’t. [...]

Stellar results from Stellar Pharmaceuticals

London-Ont.-based Stellar Pharmaceuticals (OTCBB:SLXCF) reported strong third quarter financial results today. The company’s revenues grew by 71.9%, driven by 7.9% and 303.1% growth in Canadian and International sales, respectively.   Net income grew by 42.9%.   This was the fourth consecutive quarter Stellar has generated a profit. Stellar has developed and is marketing direct in Canada and in [...]